Yamashita Health Care Holdings,Inc. (TYO:9265)
Japan · Delayed Price · Currency is JPY 3,560.00
-5.00 (-0.14%)
At close: Feb 16, 2026
TYO:9265 Income Statement
Financials in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '25 Nov 30, 2025 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
| 63,769 | 64,486 | 61,555 | 58,195 | 55,145 | 70,131 | |
Revenue Growth (YoY) | -0.39% | 4.76% | 5.77% | 5.53% | -21.37% | 8.46% |
Cost of Revenue | 55,162 | 55,709 | 53,057 | 50,147 | 47,422 | 62,621 |
Gross Profit | 8,607 | 8,777 | 8,498 | 8,048 | 7,723 | 7,510 |
Selling, General & Admin | 7,863 | 7,728 | 7,333 | 6,705 | 6,587 | 6,357 |
Amortization of Goodwill & Intangibles | 45 | 45 | 28 | 14 | 22 | 14 |
Operating Expenses | 8,073 | 7,902 | 7,476 | 6,892 | 6,793 | 6,541 |
Operating Income | 534 | 875 | 1,022 | 1,156 | 930 | 969 |
Interest Expense | -7 | -6 | - | -2 | -4 | -4 |
Interest & Investment Income | 14 | 12 | 10 | 9 | 10 | 7 |
Earnings From Equity Investments | - | -1 | -6 | -7 | 10 | 5 |
Currency Exchange Gain (Loss) | -6 | - | -4 | - | -1 | -2 |
Other Non Operating Income (Expenses) | 119 | 66 | 52 | 51 | 60 | 52 |
EBT Excluding Unusual Items | 654 | 946 | 1,074 | 1,207 | 1,005 | 1,027 |
Gain (Loss) on Sale of Investments | -2 | -3 | - | 33 | 4 | - |
Gain (Loss) on Sale of Assets | - | - | -4 | - | - | - |
Asset Writedown | - | - | -200 | - | - | - |
Other Unusual Items | - | - | - | -605 | 17 | 24 |
Pretax Income | 652 | 943 | 870 | 635 | 1,026 | 1,051 |
Income Tax Expense | 242 | 329 | 293 | 423 | 330 | 373 |
Earnings From Continuing Operations | 410 | 614 | 577 | 212 | 696 | 678 |
Minority Interest in Earnings | 2 | 2 | 3 | 7 | - | - |
Net Income | 412 | 616 | 580 | 219 | 696 | 678 |
Net Income to Common | 412 | 616 | 580 | 219 | 696 | 678 |
Net Income Growth | -5.94% | 6.21% | 164.84% | -68.53% | 2.66% | 47.71% |
Shares Outstanding (Basic) | 2 | 2 | 3 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 2 | 2 | 3 | 3 | 3 | 3 |
Shares Change (YoY) | -0.48% | -3.01% | -0.28% | - | - | -0.00% |
EPS (Basic) | 165.23 | 249.47 | 227.83 | 85.79 | 272.63 | 265.58 |
EPS (Diluted) | 165.23 | 249.47 | 227.83 | 85.79 | 272.63 | 265.58 |
EPS Growth | -5.48% | 9.50% | 165.58% | -68.53% | 2.66% | 47.71% |
Free Cash Flow | -745 | 338 | 804 | 2,121 | 474 | 765 |
Free Cash Flow Per Share | -298.78 | 136.88 | 315.81 | 830.82 | 185.67 | 299.66 |
Dividend Per Share | 75.000 | 75.000 | 70.000 | 48.000 | 82.000 | 80.000 |
Dividend Growth | 7.14% | 7.14% | 45.83% | -41.46% | 2.50% | 48.15% |
Gross Margin | 13.50% | 13.61% | 13.81% | 13.83% | 14.01% | 10.71% |
Operating Margin | 0.84% | 1.36% | 1.66% | 1.99% | 1.69% | 1.38% |
Profit Margin | 0.65% | 0.95% | 0.94% | 0.38% | 1.26% | 0.97% |
Free Cash Flow Margin | -1.17% | 0.52% | 1.31% | 3.65% | 0.86% | 1.09% |
EBITDA | 764 | 1,100 | 1,235 | 1,359 | 1,151 | 1,167 |
EBITDA Margin | 1.20% | 1.71% | 2.01% | 2.33% | 2.09% | 1.66% |
D&A For EBITDA | 230 | 225 | 213 | 203 | 221 | 198 |
EBIT | 534 | 875 | 1,022 | 1,156 | 930 | 969 |
EBIT Margin | 0.84% | 1.36% | 1.66% | 1.99% | 1.69% | 1.38% |
Effective Tax Rate | 37.12% | 34.89% | 33.68% | 66.61% | 32.16% | 35.49% |
Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.